Sensydia Corporation logo — Advancing cardiovascular care with non-invasive, point-of-ca...

Sensydia Corporation

Advancing cardiovascular care with non-invasive, point-of-care hemodynamic measurement.

Founded 2015 United States Los Angeles, United States 7 employees Grant Total: $20.80M AI, Hardware +3

General Information

Company Name Sensydia Corporation
Founded Year 2015
Location United States Los Angeles, United States +1
Employees 7
Industries AI, Hardware, Health Care +2
Funding Stage Grant
Social

Get notified when Sensydia Corporation moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Sensydia Corporation

Sensydia, founded in 2015, aims to revolutionize cardiovascular care with its non-invasive, point-of-care hemodynamic measurement platform. The company's flagship product, the Sensydia Cardiac Performance System™ (CPS), leverages proprietary sensor technology and machine learning to provide critical insights for heart failure, sepsis, pulmonary hypertension, and other critical diseases. This entirely non-invasive system, trained to the gold standard, can be deployed within minutes in various settings, from hospitals to homes. By democratizing hemodynamic insights, CPS has the potential to enable early disease detection and improve disease management. In June 2023, Sensydia secured a significant $3.00M grant investment from the National Heart, Lung and Blood Institute, underscoring the confidence of a reputable institutional investor in the company's innovative approach. With its focus on AI, hardware, healthcare, IT, and medical devices, Sensydia, headquartered in the United States, represents a promising player in the intersection of technology and healthcare.

Taxonomy: cardiovascular care, hemodynamic measurement, point-of-care technology, portable medical devices, non-invasive monitoring, sensor technology, critical patient management, heart failure, sepsis, pulmonary hypertension, early disease detection, disease management, medical innovation

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Grant •••••• 1
Investor
05 Jun 2023
Venture Round •••••• 3
Investor Investor Investor
09 May 2023
Series C •••••• - 18 Aug 2020
Series B •••••• 1
Investor
02 Aug 2017
Series A •••••• 1
Investor
01 Mar 2016

Sensydia Corporation Alternatives & Competitors

Sensydia Corporation vs
RespiQ
RespiQ The Netherlands

Smart breath testing for better health.

Grant
11 employees
Biotechnology
Sensydia Corporation vs

Innovative breath-analysis devices for non-invasive management of chronic respiratory diseases throu...

Series C
1 employees
Health Care, Medical Devices
Sensydia Corporation vs
AeenaDx
AeenaDx United States

The future...at home saliva self-collection for the detection of cancers and disease

Series A
5 employees
Biotechnology, Health Care

FAQ About Sensydia Corporation

Advancing cardiovascular care with non-invasive, point-of-care hemodynamic measurement.
Sensydia Corporation was founded in 2015.
Sensydia Corporation is headquartered in Los Angeles, United States.
Sensydia Corporation operates in the following industries: AI, Hardware, Health Care, IT, Medical Devices.
Sensydia Corporation has approximately 7 employees.
Sensydia Corporation has completed 5 funding rounds, raising a total of $20.80M. The latest funding stage is Grant.
Top alternatives and competitors to Sensydia Corporation include RespiQ, Spirometrix, Inc. (now Spirosure, Inc.), AeenaDx, HEMOLENS DIAGNOSTICS, SPACE (MedTech) Pte. Ltd. . These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Sensydia Corporation and RespiQ are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Sensydia Corporation and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy